Juan Martinez
Stories (98)
Filter by community
United States Contract Research Organization (CRO) Services Market Poised for Robust Growth Amid Rising Complexity in Clinical Trials and Expanding R&D Outsourcing. AI-Generated.
The global Contract Research Organization (CRO) services market, valued at US$79.10 billion in 2024, grew to US$84.61 billion in 2025, and is projected to achieve a resilient CAGR of 8.3% from 2025 to 2030, reaching US$125.95 billion by the end of the period. This remarkable growth trajectory reflects the increasing complexity and volume of clinical trials, coupled with a growing emphasis on patient-centric and decentralized clinical trial models. The United States Contract Research Organization (CRO) services market, in particular, continues to dominate the global landscape due to its advanced regulatory infrastructure, robust presence of key players, and substantial investment in drug development and medical innovation.
By Juan Martinez4 months ago in Journal
United States Regenerative Medicine Market Set to Transform Healthcare with Rapid Technological Advancements and Expanding Therapeutic Applications . AI-Generated.
The global regenerative medicine market, valued at US$13.5 billion in 2022, rose to US$16.0 billion in 2023 and is projected to advance at a resilient CAGR of 25.1% from 2023 to 2028, reaching a forecasted US$49.0 billion by the end of the period. The United States regenerative medicine market, representing the largest share within North America, is emerging as a dominant force due to increased clinical adoption, robust investment activity, and accelerating regulatory approvals. The market’s upward trajectory is primarily fueled by the growing emphasis on personalized medicine, expanding therapeutic scope, and the steady rise of collaborations among biotech innovators, research institutions, and pharmaceutical leaders.
By Juan Martinez4 months ago in Journal
United States Biosimilars Market Set for Robust Expansion Amid Rising Demand for Affordable Biologic Alternatives . AI-Generated.
The global biosimilars market, valued at US$32.75 billion in 2024, grew to US$35.04 billion in 2025 and is forecasted to advance at a strong CAGR of 7.5% from 2025 to 2035, reaching an estimated US$72.29 billion by the end of the period. The market’s momentum is primarily attributed to increasing regulatory approvals, a steady pipeline of product launches, and the expiration of patents on high-value biologics. The rising global prevalence of chronic diseases, combined with cost containment pressures in healthcare systems, is pushing both public and private stakeholders to adopt biosimilars as cost-effective, high-quality alternatives to biologic drugs.
By Juan Martinez4 months ago in Journal
United States Lab Automation Market Set to Surge with Rising Demand for High-Throughput Screening and AI-Driven Solutions . AI-Generated.
The United States lab automation market, a rapidly evolving segment of the global life sciences industry, is witnessing significant growth as laboratories and research institutions increasingly adopt automated solutions to enhance efficiency, precision, and productivity. Valued at US$6.36 billion in 2025, the market is projected to grow at a resilient compound annual growth rate (CAGR) of 7.2% from 2025 to 2030, reaching an estimated US$9.01 billion by the end of the forecast period. This surge is largely driven by the rising demand for high-throughput screening technologies, which enable the rapid processing of large volumes of samples in drug discovery, clinical diagnostics, and research laboratories.
By Juan Martinez4 months ago in Journal
United States GLP-1 Analogues Market Projected to Soar Amid Robust Innovation and Expanding Therapeutic Applications . AI-Generated.
The global GLP-1 (glucagon-like peptide-1) analogues market is on an extraordinary growth trajectory, reflecting one of the fastest-expanding sectors within the biopharmaceutical industry. Valued at US$37.4 billion in 2023, the market grew to US$47.4 billion in 2024 and is projected to advance at a compound annual growth rate (CAGR) of 33.2% from 2024 to 2032, ultimately reaching US$471.1 billion by the end of the forecast period.
By Juan Martinez4 months ago in Journal
United States AI in Healthcare Market Poised for Transformative Growth, Driven by Early Detection Needs and Technological Advancements . AI-Generated.
The United States Artificial Intelligence (AI) in Healthcare Market is undergoing a profound transformation, reflecting both the maturity of advanced AI tools and the evolving priorities of healthcare delivery systems. Globally, the AI in healthcare market, valued at US$14.92 billion in 2024, surged to US$21.66 billion in 2025, and is projected to achieve a remarkable CAGR of 38.6% from 2025 to 2030, ultimately reaching US$110.61 billion by the end of the forecast period.
By Juan Martinez4 months ago in Journal
United States Healthcare BPO Market Surges Amid Growing Outsourcing Trends and Technological Advancements . AI-Generated.
The healthcare business process outsourcing (BPO) sector is undergoing a major transformation, with the global healthcare BPO market valued at US$417.7 billion in 2025, up from US$337.6 billion in 2024. It is projected to grow at a compound annual growth rate (CAGR) of 10.7%, reaching an estimated US$694.3 billion by 2030. The United States healthcare BPO market remains at the forefront of this expansion, driven by a combination of regulatory shifts, digital transformation, and the increasing need to reduce operational costs across healthcare systems.
By Juan Martinez4 months ago in Journal
United States Single-Use Bioprocessing Market Poised for Robust Growth Amid Expanding Biologics Demand and Technological Advancements . AI-Generated.
The single-use bioprocessing market has entered a transformative era, marked by accelerating adoption across pharmaceutical and biotechnology industries. Valued globally at US$16.3 billion in 2023 and estimated at US$17.7 billion in 2024, the market is projected to surge to US$34.9 billion by 2029, advancing at a compound annual growth rate (CAGR) of 14.5%. The United States single-use bioprocessing market, as a pivotal regional segment, continues to lead this global shift due to its strong biopharmaceutical manufacturing base, rising biologics production, and focus on efficiency-driven process innovations.
By Juan Martinez4 months ago in Journal
United States Medical Aesthetics Market Poised for Strong Growth Driven by Demand for Non-Invasive Procedures and Technological Innovation. AI-Generated.
The medical aesthetics market is undergoing a transformative period of expansion, marked by technological innovation, shifting consumer preferences, and broader acceptance of non-invasive cosmetic treatments. Valued at US$15.59 billion in 2023, the global market rose to US$17.16 billion in 2024 and is forecasted to grow at a robust CAGR of 12.8% between 2024 and 2030, ultimately achieving a projected valuation of US$35.32 billion by the end of the decade.
By Juan Martinez4 months ago in Journal
United States In Vitro Diagnostics Market Demonstrates Steady Growth Amid Technological Advancements and Rising Chronic Disease Burden. AI-Generated.
The in vitro diagnostics (IVD) market is undergoing a significant transformation, shaped by rapid technological innovations, rising global healthcare demands, and the growing prevalence of chronic diseases. Valued at US$101,058.9 million in 2024, the global market expanded to US$109,065.5 million in 2025 and is projected to advance at a resilient CAGR of 7.6% between 2025 and 2030, culminating in a forecasted valuation of US$157,632.5 million by the end of the period.
By Juan Martinez4 months ago in Journal
United States Oligonucleotide CDMO Market Poised for Strong Growth, Driven by Therapeutic Innovation and Outsourcing Demand. AI-Generated.
The United States oligonucleotide Contract Development and Manufacturing Organization (CDMO) market is gaining momentum as the biotechnology and pharmaceutical industries intensify their investments in oligonucleotide-based therapeutics, personalized medicine, and advanced genetic tools. The global market, valued at US$2.33 billion in 2023 and reaching US$2.51 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 21.8% between 2024 and 2029, ultimately achieving a valuation of US$6.73 billion by the end of the forecast period.
By Juan Martinez4 months ago in Journal
United States Oligonucleotide Synthesis Market: Government Initiatives and Strategic Developments by Leading Players to Drive Growth. AI-Generated.
The United States oligonucleotide synthesis market is poised for substantial growth, driven by increasing demand for therapeutic and diagnostic applications, rising investment in life sciences research, and the continued emphasis on precision and personalized medicine. According to new industry insights, the global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, expanded to US$10.5 billion in 2025 and is expected to advance at a robust CAGR of 18.6% from 2025 to 2030, ultimately reaching US$24.7 billion by the end of the period.
By Juan Martinez4 months ago in Journal
